The Bipolar Illness Onset Study (the BIO Study)

NCT02888262 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2023-10-19

No results posted yet for this study

Summary

This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder

Conditions

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER
  • Mental Health Services in the Capital Region, Denmark

    lead OTHER

Principal Investigators

  • Lars V Kessing, Professor · Psychiatric Center Copenhagen

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02888262 on ClinicalTrials.gov